Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 9/20 | 0.86 |
| ▸ | MEN1 | O00255 | 1/20 | 0.86 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.86 |
| ▸ | ESR1 | P03372 | 1/20 | 0.86 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.86 |
| ▸ | HTR1A | P08908 | 1/20 | 0.86 |
| ▸ | MAPT | P10636 | 1/20 | 0.86 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.86 |
| ▸ | HPGD | P15428 | 1/20 | 0.86 |
| ▸ | MAOA | P21397 | 1/20 | 0.86 |
| ▸ | DRD1 | P21728 | 1/20 | 0.86 |
| ▸ | ACHE | P22303 | 1/20 | 0.86 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.86 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.86 |
| ▸ | PDE4A | P27815 | 1/20 | 0.86 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.86 |
| ▸ | DRD3 | P35462 | 1/20 | 0.86 |
| ▸ | BLM | P54132 | 1/20 | 0.86 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.86 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.86 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trimetrexate SCHEMBL10701228 | 0.93 | DHFR (1.00) | DHFRMEN1ALDH1A1ESR1CHRM2 | |
| Trimetrexate SCHEMBL29403928 | 0.93 | DHFR (1.00) | DHFRMEN1ALDH1A1ESR1CHRM2 | |
| Trimetrexate SCHEMBL3983 | 0.93 | DHFR (1.00) | DHFRMEN1ALDH1A1ESR1CHRM2 | |
| Trimetrexate SCHEMBL29376841 | 0.93 | DHFR (1.00) | DHFRMEN1ALDH1A1ESR1CHRM2 | |
| Trimetrexate SCHEMBL7099341 | 0.92 | DHFR (0.98) | DHFRMEN1ALDH1A1ESR1CHRM2 | |
| Trimetrexate SCHEMBL7099831 | 0.92 | DHFR (0.98) | DHFRMEN1ALDH1A1ESR1CHRM2 | |
| Trimetrexate SCHEMBL29906169 | 0.92 | DHFR (0.98) | DHFRMEN1ALDH1A1ESR1CHRM2 | |
| Trimetrexate SCHEMBL8035980 | 0.91 | DHFR (0.96) | DHFRMEN1ALDH1A1ESR1CHRM2 | |
| Trimetrexate SCHEMBL7458466 | 0.91 | DHFR (0.80) | DHFRMEN1ALDH1A1ESR1CHRM2 | |
| Trimetrexate SCHEMBL1353376 | 0.90 | DHFR (0.81) | DHFRMEN1ALDH1A1ESR1CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3463205-B1 | BIODEGRADABLE SUPPORTING DEVICE | Q3 MEDICAL DEVICES LTD (IE) | 2024-07-03 | — | — | EP | disclosed |
| US-11903851-B2 | Biodegradable supporting device | Q3 MEDICAL DEVICES LIMITED (IE) | 2024-02-20 | — | — | US | disclosed |
| US-20230263647-A1 | STENT | Q3 MEDICAL DEVICES, LIMITED (IE) | 2023-08-24 | — | — | US | disclosed |
| US-11596532-B2 | Stent | Q3 MEDICAL DEVICES LIMITED (IE) | 2023-03-07 | — | — | US | disclosed |
| EP-3941398-A1 | STENT WITH ANTI-MIGRATION DEVICES | Q3 Medical Devices Limited (IE) | 2022-01-26 | — | — | EP | disclosed |
| US-11224528-B2 | Stent | Q3 MEDICAL DEVICES LIMITED (IE) | 2022-01-18 | — | — | US | disclosed |
| US-11207199-B2 | Stent with anti-migration devices | Q3 MEDICAL DEVICES LIMITED (IE) | 2021-12-28 | — | — | US | disclosed |
| US-11173058-B2 | Stent | Q3 MEDICAL DEVICES LIMITED (IE) | 2021-11-16 | — | — | US | disclosed |
| EP-3463128-B1 | STENT | Q3 MEDICAL DEVICES LTD (IE) | 2021-11-10 | — | — | EP | disclosed |
| EP-2413845-B1 | STENT | Q3 MEDICAL DEVICES LTD (IE) | 2021-08-18 | — | — | EP | disclosed |
| EP-0841921-A2 | USE OF FLUCONAZOLE FOR INHIBITING THE GROWTH OF CANCERS | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-20 | — | — | EP | disclosed |
| EP-0841914-A2 | USE OF GRISEOFULVIN FOR INHIBITING THE GROWTH OF CANCERS | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-20 | — | — | EP | disclosed |
| EP-0841920-A2 | USE OF 1H-1,2,4-TRIAZOLE DERIVATIVES FOR INHIBITING THE GROWTH OF CANCERS | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-20 | — | — | EP | disclosed |
| EP-0821586-A1 | A PHARMACEUTICAL COMPOSITION CONTAINING BENZIMIDAZOLE FOR INHIBITING THE GROWTH OF CANCERS | THE PROCTER & GAMBLE COMPANY (US) | 1998-02-04 | — | — | EP | disclosed |
| EP-0820281-A1 | A PHARMACEUTICAL COMPOSITION CONTAINING N-CHLOROPHENYLCARBAMATES AND N-CHLOROPHENYLTHIOCARBAMATES FOR INHIBITING THE GROWTH OF VIRUSES AND CANCERS | THE PROCTER & GAMBLE COMPANY (US) | 1998-01-28 | — | — | EP | disclosed |
| WO-1997005872-A2 | USE OF 1H-1,2,4-TRIAZOLE DERIVATIVES FOR INHIBITING THE GROWTH OF CANCERS | THE PROCTER & GAMBLE COMPANY (US) | 1997-02-20 | — | — | WO | disclosed |
| WO-1997005870-A2 | USE OF GRISEOFULVIN FOR INHIBITING THE GROWTH OF CANCERS | THE PROCTER & GAMBLE COMPANY (US) | 1997-02-20 | — | — | WO | disclosed |
| WO-1997005873-A2 | USE OF FLUCONAZOLE FOR INHIBITING THE GROWTH OF CANCERS | THE PROCTER & GAMBLE COMPANY (US) | 1997-02-20 | — | — | WO | disclosed |
| WO-1996032104-A1 | A PHARMACEUTICAL COMPOSITION CONTAINING N-CHLOROPHENYLCARBAMATES AND N-CHLOROPHENYLTHIOCARBAMATES FOR INHIBITING THE GROWTH OF VIRUSES AND CANCERS | THE PROCTER & GAMBLE COMPANY (US) | 1996-10-17 | — | — | WO | disclosed |
| WO-1996032107-A1 | A PHARMACEUTICAL COMPOSITION CONTAINING BENZIMIDAZOLE FOR INHIBITING THE GROWTH OF CANCERS | THE PROCTER & GAMBLE COMPANY (US) | 1996-10-17 | — | — | WO | disclosed |